Why the study?
Does an implantable cardioverter defibrillator (ICD) reduce death compared to amiodarone in patients requiring secondary prevention?
Does an implantable cardioverter defibrillator (ICD) reduce death compared to amiodarone in patients requiring secondary prevention?
In a meta-analysis of three secondary prevention trials, ICDs significantly reduced the relative risk of all-cause death by 28% and arrhythmic death by 50% compared to amiodarone.
Answers are grounded in this paper and cite their sources.
ICDs preferred to amiodarone for secondary prevention; reinforces RCT evidence of mortality benefit.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Stuart J. Connolly (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: